Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Besson

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Revue Medicale Suisse|February 15, 2021
[About the use of ketamine in emergency psychiatric settings]Ioannis Sergentanis, Vincent Vibert, Alessandra Costanza, et al.
Brain Research|March 26, 2003
Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammationStéphanie Le Guen, Gwénaëlle Catheline, Marie Claude Fournié-Zaluski, et al.
European Journal of Pharmacology|June 14, 2002
RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal levelStéphanie Le Guen, Florence Noble, Marie-Claude Fournié-Zaluski, et al.
European Journal of Pain (London, England)|January 2, 2009
Homotopic stimulation can reduce the area of allodynia in patients with neuropathic painSarah J Love-Jones, Marie Besson, Charlotte E Steeds, et al.
Surgical Oncology|September 29, 2024
Review of definition and treatment of upper rectal cancerElias Karam, Fabien Fredon, Yassine Eid, et al.
Current Drug Metabolism|July 9, 2015
Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant PrescriptionCelia Lloret-Linares, Frank Bellivier, Emmanuel Haffen, et al.
Pain Physician|October 1, 2013
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trialAlain Matthey, Christine Cedraschi, Valerie Piguet, et al.
Journal of Personalized Medicine|October 30, 2020
Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective StudyVictoria Rollason, Célia Lloret-Linares, Kuntheavy Ing Lorenzini, et al.
Neuropharmacology|July 10, 2016
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesiaWilliam T Ralvenius, Mario A Acuña, Dietmar Benke, et al.
Plos One|July 15, 2015
Correction: Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness AnalysisAntoine Poncet, Baris Gencer, Marc Blondon, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Revue Medicale Suisse|February 15, 2021
[About the use of ketamine in emergency psychiatric settings]Ioannis Sergentanis, Vincent Vibert, Alessandra Costanza, et al.
Brain Research|March 26, 2003
Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammationStéphanie Le Guen, Gwénaëlle Catheline, Marie Claude Fournié-Zaluski, et al.
European Journal of Pharmacology|June 14, 2002
RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal levelStéphanie Le Guen, Florence Noble, Marie-Claude Fournié-Zaluski, et al.
European Journal of Pain (London, England)|January 2, 2009
Homotopic stimulation can reduce the area of allodynia in patients with neuropathic painSarah J Love-Jones, Marie Besson, Charlotte E Steeds, et al.
Surgical Oncology|September 29, 2024
Review of definition and treatment of upper rectal cancerElias Karam, Fabien Fredon, Yassine Eid, et al.
Current Drug Metabolism|July 9, 2015
Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant PrescriptionCelia Lloret-Linares, Frank Bellivier, Emmanuel Haffen, et al.
Pain Physician|October 1, 2013
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trialAlain Matthey, Christine Cedraschi, Valerie Piguet, et al.
Journal of Personalized Medicine|October 30, 2020
Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective StudyVictoria Rollason, Célia Lloret-Linares, Kuntheavy Ing Lorenzini, et al.
Neuropharmacology|July 10, 2016
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesiaWilliam T Ralvenius, Mario A Acuña, Dietmar Benke, et al.
Plos One|July 15, 2015
Correction: Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness AnalysisAntoine Poncet, Baris Gencer, Marc Blondon, et al.
Pageof 10